INVO Fertility, Inc. (IVF) Key Metrics
IVF valuation today
Trailing 12 months · as of October 18, 2026- Market cap
- $2.6M
- Enterprise value
- $3.1M
- P/E (TTM)
- 0.0
- Forward P/E
- —
- PEG ratio
- —
- Price / sales
- 0.3
- Price / book
- 0.2
- EV / EBITDA
- —
- Dividend yield
- —
- Beta
- —
IVF key metrics, 2016–2025
Fiscal year ended December 31, 2025 · U.S. dollarsIVF returns How much profit the business earns on the capital it uses.
IVF financial health Debt, liquidity and how easily interest is covered.
IVF efficiency & capital use Working capital cycle and where the cash goes.
IVF returns on capital
Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.
IVF debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease liabilities.
IVF cash returned to shareholders
IVF key metrics
2016–2025| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||
| Share price at fiscal year-end | $3.77 | $1,166.40 | $1,944.00 | $12,211.20 | $95,904.00 | $86,688.00 | $6,226.56 | $12,096.00 | $4,464.00 | $10,080.00 |
| Returns & profitability | ||||||||||
| Return on equity (ROE) | −233.6% | −133.4% | — | — | −102.0% | −822.6% | — | — | — | — |
| Return on invested capital (ROIC) | −30.3% | −44.5% | −131.0% | −339.1% | — | — | — | — | — | — |
| Return on assets (ROA) | −70.0% | −28.0% | −72.3% | −153.7% | −62.2% | −131.0% | −168.5% | −589.4% | −254.1% | −490.6% |
| Return on tangible assets | −179.2% | −189.1% | −94.2% | −293.6% | −64.4% | −76.9% | −124.7% | −401.8% | −280.8% | −795.3% |
| Free cash flow margin | −103.2% | −48.3% | −172.1% | −804.7% | −155.9% | −468.9% | 88.2% | −136.0% | −64.2% | −667.2% |
| Financial health | ||||||||||
| Total debt | $3.4M | $9.9M | $6.3M | $2.3M | $2.1M | $775,024 | $457,467 | $395,591 | $342,610 | $352,610 |
| Cash & short-term investments | $2.1M | $741,396 | $232,424 | $90,135 | $5.7M | $10.1M | $1.2M | $212,243 | $25,759 | $152,404 |
| Net debt | $1.3M | $9.2M | $6.1M | $2.2M | −$3.6M | −$9.3M | −$781,118 | $183,348 | $316,851 | $200,206 |
| Debt / equity | 0.47 | 0.78 | 7.06 | — | 0.29 | 0.13 | — | — | — | — |
| Debt / assets | 0.17 | 0.21 | 0.34 | 0.61 | 0.20 | 0.07 | 0.25 | 0.51 | 1.29 | 1.23 |
| Current ratio | 0.27 | 0.07 | 0.16 | 0.19 | 5.03 | 4.61 | 1.03 | 0.21 | 0.05 | 0.05 |
| Quick ratio | 0.25 | 0.06 | 0.12 | 0.11 | 4.80 | 4.49 | 0.96 | 0.20 | 0.03 | 0.03 |
| Interest coverage | -4.5 | -7.7 | -7.3 | -178.8 | -4.1 | -1.9 | -4.7 | -6.0 | -30.7 | -152.5 |
| Working capital | −$7.6M | −$16.6M | −$6.7M | −$2.7M | $5.1M | $8.3M | $42,330 | −$2.8M | −$4.9M | −$4.5M |
| Invested capital | $8.5M | $21.9M | $7.0M | $1.2M | $3.7M | −$3.6M | −$4.5M | −$2.5M | −$4.7M | −$4.4M |
| Tangible asset value | $20,090 | −$28.9M | −$9.1M | −$977,612 | $7.2M | $5.6M | −$3.8M | −$2.7M | −$5.0M | −$4.6M |
| Net current asset value | −$10.2M | −$32.4M | −$16.4M | −$4.1M | $3.2M | $5.3M | −$4.0M | −$2.8M | −$5.0M | −$4.7M |
| Capital allocation | ||||||||||
| Share buybacks (net) | $4.0M | $0 | — | — | — | — | — | — | — | — |
| Capex / revenue | 0.6% | 2.8% | 14.7% | 1.5% | 10.9% | 8.6% | 4.4% | 3.9% | 0.0% | 30.8% |
| Capex / operating cash flow | — | — | — | — | — | — | 4.7% | — | — | — |
| Capex / depreciation | 0.06 | 0.20 | 2.21 | 0.16 | 2.74 | 2.58 | 2.56 | 3.74 | 0.00 | 8.36 |
| Stock-based compensation / revenue | 21.5% | 24.3% | 46.1% | 270.5% | 65.1% | 169.4% | 9.0% | 423.3% | 76.2% | — |
| R&D / revenue | — | 7.5% | 5.5% | 66.2% | 5.2% | 38.4% | — | — | — | — |
| SG&A / revenue | 112.4% | 139.0% | 247.8% | 1,213.4% | 216.7% | 584.7% | — | — | — | — |
| Efficiency | ||||||||||
| Days sales outstanding | 10.5 | 8.8 | 13.2 | 28.3 | 3.2 | 5.1 | 28.8 | 115.4 | 57.9 | 14.8 |
| Days of inventory on hand | 18.8 | 24.2 | 49.8 | 118.3 | 696.0 | 754.1 | 189.3 | 206.8 | 506.1 | 1,821.3 |
| Days payables outstanding | 327.9 | 401.4 | 347.1 | 384.5 | 971.7 | 1,440.2 | 1,232.6 | 3,095.1 | 6,799.2 | 24,186.4 |
| Cash conversion cycle (days) | -298.6 | -368.4 | -284.1 | -237.9 | -272.6 | -681.0 | -1,014.5 | -2,772.9 | -6,235.2 | -22,350.3 |
| Receivables turnover | 34.89 | 41.42 | 27.75 | 12.89 | 115.29 | 70.91 | 12.68 | 3.16 | 6.31 | 24.59 |
| Payables turnover | 1.11 | 0.91 | 1.05 | 0.95 | 0.38 | 0.25 | 0.30 | 0.12 | 0.05 | 0.02 |
| Inventory turnover | 19.38 | 15.11 | 7.33 | 3.09 | 0.52 | 0.48 | 1.93 | 1.77 | 0.72 | 0.20 |
| Asset turnover | 0.21 | 0.20 | 0.27 | 0.12 | 0.39 | 0.16 | 1.15 | 0.95 | 1.02 | 0.12 |
| Average receivables | $196,072 | $157,716 | $108,850 | $63,810 | $36,084 | $14,628 | $116,728 | $156,298 | $44,746 | $2,070 |
| Average payables | $3.9M | $4.0M | $1.8M | $896,230 | $386,174 | $350,228 | $471,679 | $766,276 | $967,798 | $1.0M |
| Average inventory | $222,508 | $242,136 | $264,054 | $275,688 | $276,572 | $183,380 | $72,450 | $51,196 | $72,044 | $75,315 |
| Intangibles / total assets | 35.6% | 89.6% | 53.9% | 0.0% | 1.3% | 0.9% | 3.2% | 1.5% | 6.1% | 6.7% |
Computed from IVF's annual financial statements (latest annual report filed June 2, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.
IVF valuation and financial ratios
Based on the latest twelve months, the trailing P/E is 0.0. INVO Fertility earned a return on equity of −233.6% and a return on invested capital of −30.3% in fiscal 2025. It ended the year with $3.4 million of debt and $2.1 million in cash and short-term investments, net debt of $1.3 million. It returned $4.0 million to shareholders: $0 in dividends and $4.0 million in share buybacks.
See the IVF income statement, the IVF chart for price history, or the IVF stock overview for the latest quote and news.
IVF key metrics FAQ
What is INVO Fertility's P/E ratio?
INVO Fertility's trailing P/E ratio is 0.0 based on the last twelve months of earnings (as of October 18, 2026). At the end of fiscal 2025 it was —.
What is INVO Fertility's return on equity?
INVO Fertility's return on equity (ROE) was −233.6% in fiscal 2025: net income of -$23.3 million on average shareholders' equity of $10.0 million.
What is INVO Fertility's ROIC?
INVO Fertility's return on invested capital was −30.3% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.
How much debt does INVO Fertility have?
INVO Fertility had total debt of $3.4 million at the end of fiscal 2025, a debt-to-equity ratio of 0.47.
Does INVO Fertility buy back its shares?
Yes. INVO Fertility spent $4.0 million on net share repurchases in fiscal 2025.
What is INVO Fertility's current ratio?
INVO Fertility's current ratio was 0.27 at the end of fiscal 2025: current assets were 0.27 times current liabilities.